An outbreak of Ebola that has killed at least 85 people in West Africa is drawing aid from U.S. disease fighters who will help track the deadly path of a virus with no cure that is fatal in about 90 percent of cases.
Edwards Lifesciences Corp. and Medtronic Inc. rose in New York trading after studies were released that will increase use of their man-made valves that can be inserted into the heart without cracking open the chest.
The battle for control of a developing market for heart valves that can be inserted without open-heart surgery intensified today as Edwards Lifesciences Corp.’s second-generation product was found to outperform Medtronic Inc.’s device in a head-to-head comparison.
Medtronic Inc.’s man-made aortic valve, inserted into the heart without cracking open the chest, reduced patient death rates more than open-heart surgery in the first study to ever record such a finding.
Guinea has forbidden the sale and consumption of bats and warned against eating rats and monkeys as the country combats a spread of Ebola, a hemorrhagic fever with a mortality rate of as much as 90 percent.